» Articles » PMID: 27104752

Alterations of Dermal Connective Tissue Collagen in Diabetes: Molecular Basis of Aged-Appearing Skin

Overview
Journal PLoS One
Date 2016 Apr 23
PMID 27104752
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Alterations of the collagen, the major structural protein in skin, contribute significantly to human skin connective tissue aging. As aged-appearing skin is more common in diabetes, here we investigated the molecular basis of aged-appearing skin in diabetes. Among all known human matrix metalloproteinases (MMPs), diabetic skin shows elevated levels of MMP-1 and MMP-2. Laser capture microdissection (LCM) coupled real-time PCR indicated that elevated MMPs in diabetic skin were primarily expressed in the dermis. Furthermore, diabetic skin shows increased lysyl oxidase (LOX) expression and higher cross-linked collagens. Atomic force microscopy (AFM) further indicated that collagen fibrils were fragmented/disorganized, and key mechanical properties of traction force and tensile strength were increased in diabetic skin, compared to intact/well-organized collagen fibrils in non-diabetic skin. In in vitro tissue culture system, multiple MMPs including MMP-1 and MM-2 were induced by high glucose (25 mM) exposure to isolated primary human skin dermal fibroblasts, the major cells responsible for collagen homeostasis in skin. The elevation of MMPs and LOX over the years is thought to result in the accumulation of fragmented and cross-linked collagen, and thus impairs dermal collagen structural integrity and mechanical properties in diabetes. Our data partially explain why old-looking skin is more common in diabetic patients.

Citing Articles

Impact of High Glucose on Bone Collagenous Matrix Composition, Structure, and Organization: An Integrative Analysis Using an Ex Vivo Model.

Araujo R, Pascoa R, Bernardino R, Gomes P Cells. 2025; 14(2).

PMID: 39851558 PMC: 11764406. DOI: 10.3390/cells14020130.


The aldose reductase inhibitors AT-001, AT-003 and AT-007 attenuate human keratinocyte senescence.

Yepuri G, Kancharla K, Perfetti R, Shendelman S, Wasmuth A, Ramasamy R Front Aging. 2025; 5:1466281.

PMID: 39741583 PMC: 11685203. DOI: 10.3389/fragi.2024.1466281.


Combination therapy of negative pressure wound therapy and antibiotic-loaded bone cement for accelerating diabetic foot ulcer healing: A prospective randomised controlled trial.

Zhong M, Guo J, Qahar M, Huang G, Wu J Int Wound J. 2024; 21(10):e70089.

PMID: 39379061 PMC: 11461018. DOI: 10.1111/iwj.70089.


Dental pulp stones and their correlation with metabolic diseases.

Imran Khan M, Khare A, Arif K, Khan S, Nasir A, Lari S J Oral Maxillofac Pathol. 2024; 28(2):192-199.

PMID: 39157846 PMC: 11329071. DOI: 10.4103/jomfp.jomfp_536_23.


Ghrelin induced by ultraviolet B exposure promotes the restoration of diabetic cutaneous wound healing.

Fu Q, Peng S, Zhu C, Chen L, Sun Y, Li W Skin Res Technol. 2024; 30(8):e13919.

PMID: 39113612 PMC: 11306919. DOI: 10.1111/srt.13919.


References
1.
Muller M, Trocme C, Lardy B, Morel F, Halimi S, Benhamou P . Matrix metalloproteinases and diabetic foot ulcers: the ratio of MMP-1 to TIMP-1 is a predictor of wound healing. Diabet Med. 2008; 25(4):419-26. PMC: 2326726. DOI: 10.1111/j.1464-5491.2008.02414.x. View

2.
Wang N, Butler J, Ingber D . Mechanotransduction across the cell surface and through the cytoskeleton. Science. 1993; 260(5111):1124-7. DOI: 10.1126/science.7684161. View

3.
Benbow U, Brinckerhoff C . The AP-1 site and MMP gene regulation: what is all the fuss about?. Matrix Biol. 1997; 15(8-9):519-26. DOI: 10.1016/s0945-053x(97)90026-3. View

4.
Lopez-Lopez N, Gonzalez-Curiel I, Trevino-Santa Cruz M, Rivas-Santiago B, Trujillo-Paez V, Enciso-Moreno J . Expression and vitamin D-mediated regulation of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in healthy skin and in diabetic foot ulcers. Arch Dermatol Res. 2014; 306(9):809-21. DOI: 10.1007/s00403-014-1494-2. View

5.
Zeng W, Tahrani A, Shakher J, Varani J, Hughes S, Dubb K . Effects of a synthetic retinoid on skin structure, matrix metalloproteinases, and procollagen in healthy and high-risk subjects with diabetes. J Diabetes Complications. 2011; 25(6):398-404. PMC: 3240843. DOI: 10.1016/j.jdiacomp.2011.10.002. View